Attention Deficit Hyperactivity Disorder

Expert Q&A

Reduced Life Expectancy in ADHD

Topics: ADHD | attention | Attention Deficit Hyperactivity Disorder | Life coaching | Life expectancy | Longevity | Medication | methylphenidate | Mortality | stimulant | Teen | teens

CCPR: To start, tell us about how the thinking has changed in terms of health consequences from ADHD. Dr. Barkley: In the 1970s, we saw ADHD as an educational disorder with impacts on school behavior and academic achievement. Around that same time, there was a parallel path recognizing ADHD as a social problem in family functioning and peer relationshi

Read More
Expert Q&A

Reimagining ADHD

Topics: ADHD | attention | Attention Deficit Hyperactivity Disorder | Relationships | Teen | teens

CCPR: Thanks for speaking with us today, Dr. Hallowell. Please tell us about your work. Dr. Hallowell: I’m a writer, a speaker, and a practicing psychiatrist. I have offices in Boston, New York, San Francisco, and Seattle. I went to Harvard College, Tulane Medical School, Harvard residency, and fellowship at Mass Mental Health Center. After that I wa

Read More
Research Update

Can Stimulants Prevent Crime?

Topics: ADHD | attention | Attention Deficit Hyperactivity Disorder | Crime | Criminal behavior | Learning & Developmental Disabilities | Medication | stimulant | Teen | teens

Review of: Mohr-Jensen C et al, J Am Acad Child Adolesc Psychiatry 2019;58(4):443–452 ADHD has long been linked to antisocial behavior leading to arrests and incarcerations. Children and young adults with ADHD are more likely to be charged with anything from traffic violations to violent crimes. However, these associations do not prove causality. I

Read More
Research Update

Methylphenidate Max Dosing

Topics: ADHD | attention | Attention Deficit Hyperactivity Disorder | Medication | methylphenidate | stimulant | Teen | teens

Review of: Ching C et al, JAMA Pediatr 2019;173(7):630–639 Methylphenidate was one of the first stimulants prescribed for the treatment of ADHD in children, adolescents, and adults. Its efficacy is clear, and its availability in immediate release, sustained release, osmotic release oral system (OROS, brand name Concerta), and transdermal patch keep

Read More
Research Update

Crocus Sativus vs Methylphenidate for ADHD

Topics: ADHD | Attention Deficit Hyperactivity Disorder | Crocus Sativus | methylphenidate | Saffron

Review of: Baziar S et al, J Child Adolesc Psychopharmacol 2019;29(3):205–212 The search for an equally effective, yet better tolerated alternative to stimulant medications continues. We often hear reports on the benefits of various non-pharmaceutical supplements. Now we have a new study looking at saffron (Crocus sativus). Saffron is reported to a

Read More
News of Note

FDA Approves Adhansia XR

Topics: Adhansia XR | ADHD | adolescents | Attention Deficit Hyperactivity Disorder | Child Psychiatry | children | extended-release | methylphenidate | News of Note | pediatric | teens | treatment

We are always in need of a new formulation of stimulant medication that might capture a few more of our patients who just do not quite tolerate or respond well enough to the many existing formulations. So whenever a new one is released, we try to set aside our natural skepticism and take a look at the stated facts before judging its merit. Adhansia X

Read More
News of Note

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

Topics: ADHD | adolescents | Attention Deficit Hyperactivity Disorder | Brain Devices | Child Psychiatry | children | efficacy | eTNS | News of Note | pediatric | safety | teens | treatment | Trigeminal Nerve Stimulation

NeuroSigma made a splash by announcing that the FDA has granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications. What does medical device approval mean? The FDA reviewed the Monarch eTNS System through the de novo ­pre-market

Read More
Article

Stimulants as Cognitive Enhancers

Topics: ADHD | Amphetamines | Attention Deficit Hyperactivity Disorder | Cognition | Cosmetic pharmacology | methylphenidate

Depending on your practice setting, you are likely to encounter adults who seek stimulants for various “non-medical” uses, from cognitive enhancement to recreational abuse to outright diversion. Abuse and diversion are easier to detect these days with the controlled substance databases available in most states. Abuse of stimulants is relative

Read More